BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23073165)

  • 1. Angiocentric glioma: clinical, morphological, immunohistochemical and molecular features in three pediatric cases.
    Buccoliero AM; Castiglione F; Degl'innocenti DR; Moncini D; Spacca B; Giordano F; Genitori L; Taddei GL
    Clin Neuropathol; 2013; 32(2):107-13. PubMed ID: 23073165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
    Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
    Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
    Cykowski MD; Allen RA; Kanaly AC; Fung KM; Marshall R; Perry A; Stolzenberg ED; Dunn ST
    J Neurooncol; 2013 Dec; 115(3):477-86. PubMed ID: 24057326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiocentric glioma: a rare intractable epilepsy-related tumour in children.
    Grajkowska W; Matyja E; Daszkiewicz P; Roszkowski M; Peregud-Pogorzelski J; Jurkiewicz E
    Folia Neuropathol; 2014; 52(3):253-9. PubMed ID: 25310736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced gliomas: a report of four cases and analysis of molecular biomarkers.
    Nakao T; Sasagawa Y; Nobusawa S; Takabatake Y; Sabit H; Kinoshita M; Miyashita K; Hayashi Y; Yokoo H; Nakada M
    Brain Tumor Pathol; 2017 Oct; 34(4):149-154. PubMed ID: 28795231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A unusual brain cortical tumor: angiocentric glioma].
    Tauziède-Espariat A; Fohlen M; Ferrand-Sorbets S; Polivka M
    Ann Pathol; 2015 Apr; 35(2):154-8. PubMed ID: 25765138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset angiocentric glioma of epithelioid cell-predominant type of the mesial temporal lobe suggestive of a rare but distinct clinicopathological subset within a spectrum of angiocentric cortical ependymal tumors.
    Miyata H; Ryufuku M; Kubota Y; Ochiai T; Niimura K; Hori T
    Neuropathology; 2012 Oct; 32(5):479-91. PubMed ID: 22151480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiocentric glioma: a report of nine new cases, including four with atypical histological features.
    Ni HC; Chen SY; Chen L; Lu DH; Fu YJ; Piao YS
    Neuropathol Appl Neurobiol; 2015 Apr; 41(3):333-46. PubMed ID: 24861831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis.
    Phan K; Ng W; Lu VM; McDonald KL; Fairhall J; Reddy R; Wilson P
    World Neurosurg; 2018 Mar; 111():e539-e545. PubMed ID: 29288860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.
    Pope WB; Prins RM; Albert Thomas M; Nagarajan R; Yen KE; Bittinger MA; Salamon N; Chou AP; Yong WH; Soto H; Wilson N; Driggers E; Jang HG; Su SM; Schenkein DP; Lai A; Cloughesy TF; Kornblum HI; Wu H; Fantin VR; Liau LM
    J Neurooncol; 2012 Mar; 107(1):197-205. PubMed ID: 22015945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients.
    Das BR; Tangri R; Ahmad F; Roy A; Patole K
    Asian Pac J Cancer Prev; 2013; 14(12):7261-4. PubMed ID: 24460285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.
    Chou AP; Chowdhury R; Li S; Chen W; Kim AJ; Piccioni DE; Selfridge JM; Mody RR; Chang S; Lalezari S; Lin J; Sanchez DE; Wilson RW; Garrett MC; Harry B; Mottahedeh J; Nghiemphu PL; Kornblum HI; Mischel PS; Prins RM; Yong WH; Cloughesy T; Nelson SF; Liau LM; Lai A
    J Natl Cancer Inst; 2012 Oct; 104(19):1458-69. PubMed ID: 22945948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A juvenile case of epilepsy-associated, isocitrate dehydrogenase wild-type/histone 3 wild-type diffuse glioma with a rare BRAF
    Sadashima S; Suzuki SO; Haruyama H; Mukae N; Fujioka Y; Hata N; Mizoguchi M; Ishimatsu K; Hiwatashi A; Iwaki T
    Neuropathology; 2020 Dec; 40(6):646-650. PubMed ID: 32996219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas.
    Horbinski C; Kofler J; Yeaney G; Camelo-Piragua S; Venneti S; Louis DN; Perry A; Murdoch G; Nikiforova M
    Brain Pathol; 2011 Sep; 21(5):564-74. PubMed ID: 21314850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New IDH1 I113T mutation associated with BRAF V600E mutation: new driver of gliomagenesis?
    Tabouret E; Fina F; Vincentelli F; Nanni I; Figarella-Branger D
    J Neurol Sci; 2014 Jul; 342(1-2):204-6. PubMed ID: 24857351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: report of a secondary anaplastic astrocytoma carrying the IDH1 mutation.
    Mascelli S; Raso A; Biassoni R; Severino M; Sak K; Joost K; Milanaccio C; Barra S; Grillo-Ruggieri F; Vanni I; Consales A; Cama A; Capra V; Nozza P; Garrè ML
    J Neurooncol; 2012 Sep; 109(3):477-84. PubMed ID: 22821382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy.
    Neal A; Kwan P; O'Brien TJ; Buckland ME; Gonzales M; Morokoff A
    Epilepsy Behav; 2018 Jan; 78():30-36. PubMed ID: 29172136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
    Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
    Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
    J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.